Cargando…

Identification of SCARA3 with potential roles in metabolic disorders

Obesity is characterized by the expansion of adipose tissue which is partially modulated by adipogenesis. In the present study, we identified five differentially expressed genes by incorporating two adipogenesis-related datasets from the GEO database and their correlation with adipogenic markers. Ho...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hui, Guo, Qi, Su, Tian, Xiao, Ye, Li, Chang-Jun, Huang, Yan, Luo, Xiang-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880357/
https://www.ncbi.nlm.nih.gov/pubmed/33318306
http://dx.doi.org/10.18632/aging.202228
_version_ 1783650686942052352
author Peng, Hui
Guo, Qi
Su, Tian
Xiao, Ye
Li, Chang-Jun
Huang, Yan
Luo, Xiang-Hang
author_facet Peng, Hui
Guo, Qi
Su, Tian
Xiao, Ye
Li, Chang-Jun
Huang, Yan
Luo, Xiang-Hang
author_sort Peng, Hui
collection PubMed
description Obesity is characterized by the expansion of adipose tissue which is partially modulated by adipogenesis. In the present study, we identified five differentially expressed genes by incorporating two adipogenesis-related datasets from the GEO database and their correlation with adipogenic markers. However, the role of scavenger receptor class A member 3 (SCARA3) in obesity-related disorders has been rarely reported. We found that Scara3 expression in old adipose tissue-derived mesenchymal stem cells (Ad-MSCs) was lower than it in young Ad-MSCs. Obese mice caused by deletion of the leptin receptor gene (db/db) or by a high-fat diet both showed reduced Scara3 expression in inguinal white adipose tissue. Moreover, hypermethylation of SCARA3 was observed in patients with type 2 diabetes and atherosclerosis. Data from the CTD database indicated that SCARA3 is a potential target for metabolic diseases. Mechanistically, JUN was predicted as a transcriptional factor of SCARA3 in different databases which is consistent with our further bioinformatics analysis. Collectively, our study suggested that SCARA3 is potentially associated with age-related metabolic dysfunction, which provided new insights into the pathogenesis and treatment of obesity as well as other obesity-associated metabolic complications.
format Online
Article
Text
id pubmed-7880357
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-78803572021-02-22 Identification of SCARA3 with potential roles in metabolic disorders Peng, Hui Guo, Qi Su, Tian Xiao, Ye Li, Chang-Jun Huang, Yan Luo, Xiang-Hang Aging (Albany NY) Research Paper Obesity is characterized by the expansion of adipose tissue which is partially modulated by adipogenesis. In the present study, we identified five differentially expressed genes by incorporating two adipogenesis-related datasets from the GEO database and their correlation with adipogenic markers. However, the role of scavenger receptor class A member 3 (SCARA3) in obesity-related disorders has been rarely reported. We found that Scara3 expression in old adipose tissue-derived mesenchymal stem cells (Ad-MSCs) was lower than it in young Ad-MSCs. Obese mice caused by deletion of the leptin receptor gene (db/db) or by a high-fat diet both showed reduced Scara3 expression in inguinal white adipose tissue. Moreover, hypermethylation of SCARA3 was observed in patients with type 2 diabetes and atherosclerosis. Data from the CTD database indicated that SCARA3 is a potential target for metabolic diseases. Mechanistically, JUN was predicted as a transcriptional factor of SCARA3 in different databases which is consistent with our further bioinformatics analysis. Collectively, our study suggested that SCARA3 is potentially associated with age-related metabolic dysfunction, which provided new insights into the pathogenesis and treatment of obesity as well as other obesity-associated metabolic complications. Impact Journals 2020-12-09 /pmc/articles/PMC7880357/ /pubmed/33318306 http://dx.doi.org/10.18632/aging.202228 Text en Copyright: © 2020 Peng et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Peng, Hui
Guo, Qi
Su, Tian
Xiao, Ye
Li, Chang-Jun
Huang, Yan
Luo, Xiang-Hang
Identification of SCARA3 with potential roles in metabolic disorders
title Identification of SCARA3 with potential roles in metabolic disorders
title_full Identification of SCARA3 with potential roles in metabolic disorders
title_fullStr Identification of SCARA3 with potential roles in metabolic disorders
title_full_unstemmed Identification of SCARA3 with potential roles in metabolic disorders
title_short Identification of SCARA3 with potential roles in metabolic disorders
title_sort identification of scara3 with potential roles in metabolic disorders
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880357/
https://www.ncbi.nlm.nih.gov/pubmed/33318306
http://dx.doi.org/10.18632/aging.202228
work_keys_str_mv AT penghui identificationofscara3withpotentialrolesinmetabolicdisorders
AT guoqi identificationofscara3withpotentialrolesinmetabolicdisorders
AT sutian identificationofscara3withpotentialrolesinmetabolicdisorders
AT xiaoye identificationofscara3withpotentialrolesinmetabolicdisorders
AT lichangjun identificationofscara3withpotentialrolesinmetabolicdisorders
AT huangyan identificationofscara3withpotentialrolesinmetabolicdisorders
AT luoxianghang identificationofscara3withpotentialrolesinmetabolicdisorders